These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18223693)

  • 1. Reciprocal negative regulation between S100A7/psoriasin and beta-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity.
    Zhou G; Xie TX; Zhao M; Jasser SA; Younes MN; Sano D; Lin J; Kupferman ME; Santillan AA; Patel V; Gutkind JS; Ei-Naggar AK; Emberley ED; Watson PH; Matsuzawa SI; Reed JC; Myers JN
    Oncogene; 2008 Jun; 27(25):3527-38. PubMed ID: 18223693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells.
    Deol YS; Nasser MW; Yu L; Zou X; Ganju RK
    J Biol Chem; 2011 Dec; 286(52):44845-54. PubMed ID: 22016394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway.
    Dey KK; Bharti R; Dey G; Pal I; Rajesh Y; Chavan S; Das S; Das CK; Jena BC; Halder P; Ray JG; Kulavi I; Mandal M
    Cancer Gene Ther; 2016 Nov; 23(11):382-391. PubMed ID: 27767088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis.
    Webb M; Emberley ED; Lizardo M; Alowami S; Qing G; Alfia'ar A; Snell-Curtis LJ; Niu Y; Civetta A; Myal Y; Shiu R; Murphy LC; Watson PH
    BMC Cancer; 2005 Feb; 5():17. PubMed ID: 15717926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.
    Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X
    PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasin (S100A7) expression is altered during skin tumorigenesis.
    Alowami S; Qing G; Emberley E; Snell L; Watson PH
    BMC Dermatol; 2003 Feb; 3():1. PubMed ID: 12600274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation.
    Paruchuri V; Prasad A; McHugh K; Bhat HK; Polyak K; Ganju RK
    PLoS One; 2008 Mar; 3(3):e1741. PubMed ID: 18320059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells.
    Petersson S; Bylander A; Yhr M; Enerbäck C
    BMC Cancer; 2007 Nov; 7():205. PubMed ID: 17986321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic attributes of S100A7 (psoriasin) in resistance of anoikis resulting tumor progression in squamous cell carcinoma of the oral cavity.
    Dey KK; Sarkar S; Pal I; Das S; Dey G; Bharti R; Banik P; Roy J; Maity S; Kulavi I; Mandal M
    Cancer Cell Int; 2015; 15():74. PubMed ID: 26225121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling.
    Sneh A; Deol YS; Ganju A; Shilo K; Rosol TJ; Nasser MW; Ganju RK
    Breast Cancer Res Treat; 2013 Apr; 138(3):727-39. PubMed ID: 23535840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling.
    Liu H; Wang L; Wang X; Cao Z; Yang Q; Zhang K
    World J Surg Oncol; 2013 Apr; 11():93. PubMed ID: 23618129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [S100A7 promotes the metastasis and epithelial-mesenchymal transition on HeLa and CaSki cells].
    Tian T; Hua Z; Wang LZ; Wang XY; Chen HY; Liu ZH; Cui ZM
    Zhonghua Fu Chan Ke Za Zhi; 2018 Feb; 53(2):99-105. PubMed ID: 29534378
    [No Abstract]   [Full Text] [Related]  

  • 14. Knockdown of Nav1.5 inhibits cell proliferation, migration and invasion via Wnt/β-catenin signaling pathway in oral squamous cell carcinoma.
    Xu X; Dai Y; Feng L; Zhang H; Hu Y; Xu L; Zhu X; Jiang Y
    Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):527-535. PubMed ID: 32400862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription promoter activity of the human S100A7 gene in oral squamous cell carcinoma cell lines.
    Fukuzawa H; Kiyoshima T; Kobayashi I; Ozeki S; Sakai H
    Biochim Biophys Acta; 2006; 1759(3-4):171-6. PubMed ID: 16675044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A7 (psoriasin) influences immune response genes in human breast cancer.
    Mandal S; Curtis L; Pind M; Murphy LC; Watson PH
    Exp Cell Res; 2007 Aug; 313(14):3016-25. PubMed ID: 17560571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytoplasmic domain of N-cadherin modulates MMP‑9 induction in oral squamous carcinoma cells.
    Walker A; Frei R; Lawson KR
    Int J Oncol; 2014 Oct; 45(4):1699-706. PubMed ID: 25175499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
    Nasser MW; Qamri Z; Deol YS; Ravi J; Powell CA; Trikha P; Schwendener RA; Bai XF; Shilo K; Zou X; Leone G; Wolf R; Yuspa SH; Ganju RK
    Cancer Res; 2012 Feb; 72(3):604-15. PubMed ID: 22158945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the Wnt-β-catenin pathway in invasion and migration of oral squamous carcinoma cells.
    Iwai S; Yonekawa A; Harada C; Hamada M; Katagiri W; Nakazawa M; Yura Y
    Int J Oncol; 2010 Nov; 37(5):1095-103. PubMed ID: 20878057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
    Zhao H; Wilkie T; Deol Y; Sneh A; Ganju A; Basree M; Nasser MW; Ganju RK
    Mol Cancer; 2015 Jan; 14():11. PubMed ID: 25622979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.